UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 9, 2026
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
(Address of principal executive offices, including zip code)
(561 ) 237-4152
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter):
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Departure of Principal Accounting Officer and Named Executive Officer
On March 9, 2026, it was determined that, as of March 10, 2026 (the “Effective Date”), James V. Redd III will cease to serve as the Senior Vice President and Chief
Accounting Officer of Cross Country Healthcare, Inc. (the “Company”) and that Phil Noe will cease to serve as Chief Information Officer of the Company. Neither Mr. Redd’s departure nor Mr. Noe’s departure was the result of any dispute or
disagreement with the Company, including with respect to any matters relating to the Company’s accounting practices or financial reporting.
Appointment of Principal Accounting Officer
On March 9, 2026, the Company’s Board of Directors appointed Marvin Veizaga as its Senior Vice President, Chief Accounting Officer (the “Appointment”), with such
Appointment to be effective as of the Effective Date. Mr. Veizaga, 45, has been employed with the Company since 2015, most recently serving as its Group Vice President, Corporate Controller. From 2021 to 2023, he served as the Company’s Vice
President, Assistant Controller, and from 2020 to 2021, he was the Company’s Vice President, Business Unit Controller. Prior to joining the Company, Mr. Veizaga served as a Senior Auditor at Deloitte & Touche LLP from 2012 to 2015. Mr. Veizaga
is a certified public accountant and holds a Bachelor of Science in Accounting from Florida Atlantic University.
In connection with the Appointment, the Company and Mr. Veizaga entered into that certain Letter Agreement, dated as of March 10, 2026 (the “Letter Agreement”).
Pursuant to the Letter Agreement, effective as of the Effective Date, Mr. Veizaga’s base salary will be increased to $340,000, and he will be eligible for an annual short-term incentive bonus target amount of 50% of his base salary under the
Company’s Annual Cash Incentive Program. The Letter Agreement also provides that Mr. Veizaga will be eligible to receive an annual long-term incentive equity award with a target value equal to 50% of his base salary.
There is no arrangement or understanding between Mr. Veizaga and any other person pursuant to which Mr. Veizaga was appointed Principal Accounting Officer, nor
does he have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Mr. Veizaga has no family relationships with any of the Company’s directors or executive officers. The
foregoing summary of the Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter Agreement, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits
Exhibit Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline
XBRL document)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
CROSS COUNTRY HEALTHCARE, INC.
Dated: March 10, 2026
By: /s/ William J. Burns
Executive Vice President & Chief Financial Officer
Exhibit 10.1
To: Marvin Veizaga
From: Colin McDonald
Chief Human Resources Officer
Date: March 10, 2026
RE: Promotion | Salary Adjustment
Congratulations, Marvin!
This memo confirms your promotion to Senior Vice President, Chief Accounting Officer, effective March 10, 2026. You will report to William
Burns, Executive Vice President , Chief Financial Officer.
Your new bi-weekly rate of pay will be $13,076.92, which, when annualized, is equivalent to $340,000.00.
Your Short-Term Incentive target will remain at 50% of your base salary for 2026. Your Long-Term Incentive target will increase
to 50% of your base salary, also effective in 2026.
Accompanying this memo is a new job description for your review and signature acknowledgement. All other terms and conditions of your employment remain unchanged.
We wish you the best in your new role and we look forward to your continued contribution to the success of the organization.
Please feel free to reach out to me if you have any questions.
Cc: Employee file.
I understand and agree to the terms outlined above.
/s/ Marvin Veizaga March 10, 2026
Marvin Veizaga Date